Zila, Inc.
16430 North Scottsdale Road
Suite 450
Scottsdale,
AZ 85254-1770
United States - Map
Phone: 602-266-6700
Fax: 602-234-2264
Web Site: http://www.zila.com
| Zila, Inc., a diagnostic company, engages in the prevention, detection, and treatment of oral cancer and periodontal disease. It manufactures and markets ViziLite Plus with TBlue, its flagship product, for early detection of oral abnormalities that could lead to cancer. In addition, the company designs, manufactures, and markets a suite of proprietary products directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler, and a portfolio of oral pharmaceutical products for in-office and home-care use. Further, it had certain technology rights, and the United States and foreign patent rights related to the OraTest, an oral cancer diagnostic product. Zila, Inc. markets and sells its products in the United States and Canada through direct sales force, and internationally through third party distributors. The company was founded in 1980 and is headquartered in Phoenix, Arizona. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David R. Bethune , 68
Exec. Chairman and Chief Exec. Officer |
$
271.00K | N/A | Ms. Diane E. Klein , 61
Principal Financial Officer, VP of Fin. and Treasurer |
N/A
| N/A | Mr. Gary V. Klinefelter , 60
VP, Sec. and Gen. Counsel |
N/A
| N/A | Dr. Yu Ping Maguire Ph.D.,
Head of Clinical and Head of Regulatory Affairs |
N/A
| N/A | Mr. G. Warren Chane Jr.,
VP of Corp. Bus. Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.06% Nasdaq 0.00%
Profile
